Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oroxid is a patented, active oxygen-based medical device for topical use in the oral cavity. Its primary active ingredient is hydrogen peroxide (typically at 1.5% concentration), which releases active oxygen upon contact with oral tissues. This mechanism mimics the natural oxidative defense of immune cells by generating singlet oxygen and water, leading to antimicrobial effects against bacteria, fungi, and viruses. The released oxygen also promotes tissue regeneration and healing by enhancing cellular oxygenation and energy production in mitochondria. Oroxid products are indicated for intensive oral hygiene and the treatment of various oral conditions such as gingivitis, periodontitis, aphthae (mouth ulcers), stomatitis, bleeding gums, bad breath (halitosis), post-surgical care (e.g., after tooth extraction or tonsil procedures), plaque reduction, stain removal from teeth surfaces, and general inflammation or irritation of the oral mucosa[4][5][6][7]. Different formulations exist for adults ("Forte") and those with sensitive mucosa ("Sensitiv"), including sprays and gels[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oroxid.